Most Viewed Abstracts
1. Report Shows Shift in Starting Salaries for Physicians 2. Recommendations on the use of 18F-FDG PET in oncology 3. Taxane-based combinations as adjuvant chemotherapy of early breast cancer: a meta-analysis of randomized trials 4. Gene expression signatures, clinicopathological features, and individualized therapy in breast cancer 5. Sentinel node biopsy is important in mastectomy for ductal carcinoma in situ
Top Ten Searches
brca1 prostate-specific antigen sclc fobt egd bmi dysplasia hematologic ovarian hccYour Article Summary
Daily labile plasma iron as an indicator of chelator activity in Thalassaemia major patients
British Journal of Haematology, 09/23/09
Zanninelli G et al. – Although the clinical significance and therapeutic value of LPI remain to be established, monitoring of daily LPI level may provide an analytical basis for assessing chelation efficacy in preventing daily LPI recrudescence.
Related Articles
Noninvasive assessment of liver fibrosis in thalassaemia major patients by transient elastography (TE) – lack of interference by iron deposition
British Journal of Haematology, 12/01/09
Relevance Score: 66%
Normalisation of total body iron load with very intensive combined chelation reverses cardiac and endocrine complications of thalassaemia major
British Journal of Haematology, 11/20/09
Relevance Score: 64%
Rivaroxaban, the first oral, direct factor Xa inhibitor
Expert Opinion in Pharmacotherapy, 11/24/09
Relevance Score: 45%
Increased Cold-Pain Thresholds in Major Depression
The Journal of Pain, 12/03/09
Relevance Score: 44%
Hypercoagulable State and Methylenetetra- hydrofolate Reductase (MTHFR) C677T Mutation in Patients with Beta-Thalassemia Major in Kuwait
Acta Haematologica, 11/24/09
Relevance Score: 43%
Today in Anemia/Polycythemia...keeping you current
Receive free subspecialty "5-minute updates" via email
Red Blood Cell Distribution Width and Risk of Cardiovascular Events and Mortality in a Community Cohort in Taiwan
American Journal of Epidemiology, 12/16/09
Prolonged anemia in an intrauterine-transfused neonate with Rh-hemolytic disease: no evidence for anti-D–related suppression of erythropoiesis in vitro
Transfusion, 12/16/09
Spanish Society of Medical Oncology consensus on the use of erythropoietic stimulating agents in anaemic cancer patients
Clinical and Translational Oncology, 12/14/09
Sponsor
Article Search
Sponsor
Sponsor


See Latest Articles


